Isomorphic Labs Secures $5 Billion to Advance AI-Designed Drugs into Clinical Trials
Trendline

Isomorphic Labs Secures $5 Billion to Advance AI-Designed Drugs into Clinical Trials

What's Happening? Isomorphic Labs, an AI drug design company spun out of Google DeepMind, has successfully raised $5 billion in a Series C financing round. This significant investment, co-led by Greenoaks and Sequoia Capital, with participation from Andreessen Horowitz and continued backing from Alp
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.